Ordering
Available Variants25 mg
CHA.29589-25mg
Price
€582.40
Available – Dispatch in 14 days
100 mg
CHA.29589-100mg
Price
€506.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.29589-25mg | €582.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.29589-100mg | €506.40 |
≥90%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C25H42N7O18P3S |
|---|---|
| CAS Number | 103404-51-9 |
| Molecular Weight | 853.62 |
| NACRES | NA.51 |
| PubChem Substance ID | 24895396 |
| UNSPSC Code | 41106305 |
| MDL number | MFCD00079336 |
| Form | powder |
| Assay | ≥90% |
| Solubility | H2O: soluble-50 mg/mL, clear, colorless |
| Biological source | synthetic (Organic) |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
3-Hydroxy-DL-kynurenine, with the CAS number 2147-61-7, is a compound of interest in various biochemical and pharmacological studies. This kynurenine derivative is involved in the tryptophan metabolism pathway, where it plays a crucial role as an intermediate. The compounds structure consists of a hydroxyl group attached to the kynurenine backbone, which affects its reactivity and interaction with other molecules. Research on 3-Hydroxy-DL-kynurenine has explored its potential implications in neurological disorders and diseases, given its connection to the kynurenine pathway, which is known to be altered in certain pathological conditions. Further investigation into the properties and biological activities of 3-Hydroxy-DL-kynurenine may uncover new insights into its therapeutic potential and shed light on the underlying mechanisms of related diseases. Its study contributes to the broader understanding of tryptophan metabolism and its significance in human health.
